Stay updated on Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial
Sign up to get notified when there's something new on the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page.

Latest updates to the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page
- Check6 days agoChange DetectedDifference0.3%
- Check13 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check20 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.3%
- Check28 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.7%
- Check35 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an opportunity for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.6%
- Check42 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.5%
Stay in the know with updates to Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page.